Goldman Sachs’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,340
| Closed | -$213K | – | 6791 |
|
|
2025
Q4 | $213K | Buy |
+14,340
| New | +$250K | ﹤0.01% | 6018 |
|
|
2025
Q2 | – | Sell |
-3,731
| Closed | -$52.2K | – | 6287 |
|
|
2025
Q1 | $52.2K | Buy |
3,731
+1,083
| +41% | +$17K | ﹤0.01% | 5874 |
|
|
2024
Q4 | $44K | Buy |
2,648
+1,915
| +261% | +$31.1K | ﹤0.01% | 5850 |
|
|
2024
Q3 | $13.9K | Sell |
733
-32,615
| -98% | -$662K | ﹤0.01% | 5690 |
|
|
2024
Q2 | $483K | Sell |
33,348
-19,859
| -37% | -$331K | ﹤0.01% | 4851 |
|
|
2024
Q1 | $824K | Buy |
53,207
+31,414
| +144% | +$677K | ﹤0.01% | 4465 |
|
|
2023
Q4 | $610K | Sell |
21,793
-13,250
| -38% | -$348K | ﹤0.01% | 4644 |
|
|
2023
Q3 | $1.67M | Buy |
35,043
+2,203
| +7% | +$168K | ﹤0.01% | 3908 |
|
|
2023
Q2 | $3.15M | Buy |
32,840
+16,803
| +105% | +$1.83M | ﹤0.01% | 3512 |
|
|
2023
Q1 | $1.82M | Sell |
16,037
-683
| -4% | -$73.9K | ﹤0.01% | 3939 |
|
|
2022
Q4 | $1.87M | Buy |
16,720
+3,443
| +26% | +$462K | ﹤0.01% | 3993 |
|
|
2022
Q3 | $1.71M | Sell |
13,277
-10,300
| -44% | -$1.05M | ﹤0.01% | 4105 |
|
|
2022
Q2 | $1.62M | Sell |
23,577
-7,850
| -25% | -$676K | ﹤0.01% | 4226 |
|
|
2022
Q1 | $4.47M | Sell |
31,427
-30,496
| -49% | -$4.69M | ﹤0.01% | 3460 |
|
|
2021
Q4 | $10.3M | Buy |
61,923
+33,347
| +117% | +$5.3M | ﹤0.01% | 2730 |
|
|
2021
Q3 | $3.98M | Sell |
28,576
-7,549
| -21% | -$1.48M | ﹤0.01% | 3553 |
|
|
2021
Q2 | $17.2M | Sell |
36,125
-9,331
| -21% | -$3.94M | ﹤0.01% | 2184 |
|
|
2021
Q1 | $18.7M | Buy |
45,456
+8,225
| +22% | +$3.79M | ﹤0.01% | 1991 |
|
|
2020
Q4 | $18.2M | Buy |
37,231
+32,601
| +704% | +$19.1M | ﹤0.01% | 1940 |
|
|
2020
Q3 | $2.62M | Sell |
4,630
-13,690
| -75% | -$4.55M | ﹤0.01% | 3372 |
|
|
2020
Q2 | $1.74M | Buy |
18,320
+9,991
| +120% | +$877K | ﹤0.01% | 3558 |
|
|
2020
Q1 | $594K | Buy |
8,329
+136
| +2% | +$9.12K | ﹤0.01% | 4108 |
|
|
2019
Q4 | $565K | Buy |
8,193
+2,476
| +43% | +$184K | ﹤0.01% | 4432 |
|
|
2019
Q3 | $459K | Sell |
5,717
-25,663
| -82% | -$1.7M | ﹤0.01% | 4492 |
|
|
2019
Q2 | $2.02M | Buy |
31,380
+25,974
| +480% | +$2.47M | ﹤0.01% | 3548 |
|
|
2019
Q1 | $743K | Buy |
5,406
+1,944
| +56% | +$237K | ﹤0.01% | 4220 |
|
|
2018
Q4 | $313K | Sell |
3,462
-578
| -14% | -$80.9K | ﹤0.01% | 4609 |
|
|
2018
Q3 | $613K | Buy |
4,040
+428
| +12% | +$69.2K | ﹤0.01% | 4311 |
|
|
2018
Q2 | $621K | Buy |
3,612
+1,586
| +78% | +$259K | ﹤0.01% | 4385 |
|
|
2018
Q1 | $297K | Sell |
2,026
-451
| -18% | -$86.5K | ﹤0.01% | 4787 |
|
|
2017
Q4 | $502K | Buy |
2,477
+1,042
| +73% | +$214K | ﹤0.01% | 4830 |
|
|
2017
Q3 | $460K | Buy |
1,435
+269
| +23% | +$73.5K | ﹤0.01% | 5151 |
|
|
2017
Q2 | $263K | Sell |
1,166
-1,055
| -48% | -$217K | ﹤0.01% | 5605 |
|
|
2017
Q1 | $501K | Buy |
2,221
+443
| +25% | +$89.9K | ﹤0.01% | 5032 |
|
|
2016
Q4 | $352K | Buy |
1,778
+785
| +79% | +$171K | ﹤0.01% | 5354 |
|
|
2016
Q3 | $244K | Buy |
993
+263
| +36% | +$92.3K | ﹤0.01% | 5647 |
|
|
2016
Q2 | $424K | Sell |
730
-2,150
| -75% | -$1.26M | ﹤0.01% | 5006 |
|
|
2016
Q1 | $1.53M | Buy |
2,880
+1,824
| +173% | +$952K | ﹤0.01% | 3720 |
|
|
2015
Q4 | $741K | Buy |
1,056
+455
| +76% | +$299K | ﹤0.01% | 4582 |
|
|
2015
Q3 | $357K | Buy |
+601
| New | +$490K | ﹤0.01% | 5457 |
|
Other funds holding MCRB
FP
VCM
VFT
